Beneficient (BENF) EBIAT (2021 - 2025)
Beneficient (BENF) has disclosed EBIAT for 5 consecutive years, with $5.9 million as the latest value for Q4 2025.
- Quarterly EBIAT rose 158.09% to $5.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$149.2 million through Dec 2025, up 1.64% year-over-year, with the annual reading at -$803000.0 for FY2025, 99.97% up from the prior year.
- EBIAT hit $5.9 million in Q4 2025 for Beneficient, up from -$17.9 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $44.3 million in Q2 2024 to a low of -$1.2 billion in Q2 2023.
- Historically, EBIAT has averaged -$181.4 million across 5 years, with a median of -$44.6 million in 2025.
- Biggest five-year swings in EBIAT: tumbled 2055.88% in 2023 and later soared 158.09% in 2025.
- Year by year, EBIAT stood at -$23.0 million in 2021, then crashed by 86.81% to -$42.9 million in 2022, then crashed by 2055.88% to -$924.9 million in 2023, then surged by 98.89% to -$10.2 million in 2024, then skyrocketed by 158.09% to $5.9 million in 2025.
- Business Quant data shows EBIAT for BENF at $5.9 million in Q4 2025, -$17.9 million in Q3 2025, and -$92.6 million in Q2 2025.